Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (18) Bähring, Sylvia Dr. (1) Birchmeier, Walter Prof. Dr. (23) Birchmeier-Kohler, Carmen Prof. Dr. (10) Dechend, Ralf Priv. Doz. (5) Falcke, Martin Prof. Dr. (4) Gotthardt, Michael Prof. Dr. (1) Hübner, Norbert Prof. Dr. (8) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Jentsch, Thomas Prof. Dr. (20) Kettenmann, Helmut Prof. Dr. (28) Kettritz, Ralph Prof. Dr. (4) Klußmann, Enno PD Dr. (1) Kühn, Ralf Dr. (10) Lee, Young-Ae Prof. Dr. (2) Leutz, Achim Prof. Dr. (7) Lewin, Gary Prof. Dr. (5) Luft, Friedrich Prof. Dr. (54) Morano, Ingo Prof. Dr. (10) Niendorf, Thoralf Prof. Dr. (5) Rajewsky, Klaus Prof. Dr. (7) Rajewsky, Nikolaus Prof. Dr. (1) Sander, Maike Prof. Dr. (3) Spuler, Simone Prof. (3) Stein, Ulrike Prof. Dr. (9) Walther, Wolfgang Prof. Dr. (9) Wanker, Erich Prof. Dr. (4) Willnow, Thomas Prof. Dr. (10) (-) Blankenstein, Thomas Prof. Dr. (13) (-) Müller, Dominik Prof. Dr. (1) (-) Scheidereit, Claus Prof. Dr. (2) (-) Schulz-Menger, Jeanette Prof. Dr. (1) 1992 (7) 1993 (10) (-) 1994 (8) (-) 1995 (9) 1996 (11) 1997 (14) 1999 (13) 2000 (25) 2001 (26) 2002 (18) 2003 (23) 2004 (21) 2005 (29) 2006 (13) 2007 (24) 2008 (29) 2009 (24) 2010 (42) 2011 (36) 2012 (31) 2013 (39) 2014 (29) 2015 (28) 2016 (35) 2017 (33) 2018 (32) 2019 (35) 2020 (40) 2021 (41) 2022 (36) 2023 (41) 2024 (15) AG Müller/Dechend (ECRC) (1) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Molecular Immunology and Gene Therapy (13) 17 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Müller, Dominik Prof. Dr.Scheidereit, Claus Prof. Dr.Schulz-Menger, Jeanette Prof. Dr.19941995 Sort: Result score Newest to oldest Oldest to newest January 01, 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein January 01, 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein January 01, 1994 / Fibrinolysis Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system R. Dechend S. Hauck J. Eichhorn W. Goedecke M. Praus J. Schulz-Menger M. Barthels R. Dietz D. Gulba January 01, 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein August 05, 1994 / J Biol Chem Identification of novel ubiquitous and cell type-specific factors that specifically recognize immunoglobulin heavy and light chain promoters S. Franke G. Scholz C. Scheidereit October 03, 1994 / EMBO J Activation of NF-kappaB in vivo is regulated by multiple phosphorylations M. Naumann C. Scheidereit January 01, 1995 / Canc Gene Ther Vectors in cancer therapy: how will they deliver M. Blaese T. Blankenstein M. Brenner O. Cohen-Haguenauer B. Gansbacher S. Russell B. Sorrentino T. Velu January 01, 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein January 01, 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling January 01, 1995 / Hypertension Effects of human renin in the vasculature of rats transgenic for human angiotensinogen D.N. Mueller K.F. Hilgers J. Bohlender A. Lippoldt J. Wagner W. Fischli D. Ganten J.F.E. Mann F.C. Luft Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein
January 01, 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein
January 01, 1994 / Fibrinolysis Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system R. Dechend S. Hauck J. Eichhorn W. Goedecke M. Praus J. Schulz-Menger M. Barthels R. Dietz D. Gulba
January 01, 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein
August 05, 1994 / J Biol Chem Identification of novel ubiquitous and cell type-specific factors that specifically recognize immunoglobulin heavy and light chain promoters S. Franke G. Scholz C. Scheidereit
October 03, 1994 / EMBO J Activation of NF-kappaB in vivo is regulated by multiple phosphorylations M. Naumann C. Scheidereit
January 01, 1995 / Canc Gene Ther Vectors in cancer therapy: how will they deliver M. Blaese T. Blankenstein M. Brenner O. Cohen-Haguenauer B. Gansbacher S. Russell B. Sorrentino T. Velu
January 01, 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein
January 01, 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling
January 01, 1995 / Hypertension Effects of human renin in the vasculature of rats transgenic for human angiotensinogen D.N. Mueller K.F. Hilgers J. Bohlender A. Lippoldt J. Wagner W. Fischli D. Ganten J.F.E. Mann F.C. Luft